Efficacia comparativa e sicurezza nel mondo reale di tofacitinib e baricitinib in pazienti con artrite reumatoide
Arthritis Res Ther. 2021;23(1):197In a real-world setting, tofacitinib and baricitinib have comparable continuing efficacies and safety profiles in patients with RA.It is important to determine the differences and similarities of JAK inhibitors in a real-world setting so that the optimal agent can be administered. However, until now, no published data of a direct comparison among these agents in RA have been available. With this in mind, Iwamoto, et al. compared the efficacy and safety of tofacitinib with those of baricitinib by...